Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharmacy and Chemistry

Review

Junbo Zhang¹  Hongmei Jia¹  Ralph Santos Oliveira²  Sarah Spreckelmeyer³  Tamer Sakr⁴  Mohammed Al-Qahtani⁵  Antony D. Gee⁶  Peter Caravan⁷  Clemens Decristoforo⁸  Jeroen Hendrikx⁹  Jan Rijn Zeevaart^1,10  Xing Yang^1,11  Sietske Rubow^1,12  Hua Yang^1,13  Giuseppe Carlucci^1,14  Miguel Avila Rodriquez^1,15  Marcela Zubillaga^1,16  Adriano Duatti^1,17  Wiktor Szymanski^1,18  Guy Bormans^1,19  Jean DaSilva^2,20  Robert H. Mach^2,21 

[1] Beijing Normal University, Beijing, China;Brazilian Association of Radiopharmacy Brazil, Brazilian Nuclear Energy Commission - Nuclear Engineering Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil;Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany;Egyptian Atomic Energy Authority, Cairo, Egypt;King Faisal Specialist Hospital and Research Center, Riad, Saudi Arabia;King’s College, London, UK;Massuchusetts General Hospital, Harvard University, Boston, USA;Medical University Innsbruck, Innsbruck, Austria;NKI, Amsterdam, The Netherlands;Necsa, Pretoria, South Africa;Peking University First Hospital, Beijing, China;Stellenbosch University, Stellenbosch, South Africa;TRIUMF, Vancouver, Canada;UCLA, Los Angeles, USA;Universidad Nacional Autonoma de Mexico (UNAM), Mexico-City, Mexico;University of Buenos Aires, Buenos Aires, Argentina;University of Ferrara, Ferrara, Italy;University of Groningen, Groningen, The Netherlands;University of Leuven, Leuven, Belgium;University of Montreal, Montreal, Canada;University of Pennsylvania, Philadelphia, USA;

关键词: Highlight articles;    Radiochemistry;    Radiopharmacy;    Radiopharmaceutical sciences;    Nuclear medicine;    Trends in radiopharmaceutical sciences;   

DOI  :  10.1186/s41181-023-00218-y

 received in 2023-10-04, accepted in 2023-10-13,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundThe Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.Main bodyThis selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.ConclusionTrends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 2

Fig. 2

Fig. 2

Fig. 1

Fig. 1